+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Liver And Kidney Disorders Drugs Market Research Reports

Kidney Stone Retrieval Devices Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2019-2029F - Product Thumbnail Image

Kidney Stone Retrieval Devices Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2019-2029F

  • Report
  • April 2024
  • 180 Pages
  • Global
From
Egypt Hepatitis C Testing Market, By Test By Technique, By End User, By Region, Competition Forecast and Opportunities, 2027 - Product Thumbnail Image

Egypt Hepatitis C Testing Market, By Test By Technique, By End User, By Region, Competition Forecast and Opportunities, 2027

  • Report
  • August 2023
  • 73 Pages
  • Egypt
From
Renal Denervation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented by Technology, By Product, By Therapeutic Area, By End User, By Region and Competition - Product Thumbnail Image

Renal Denervation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented by Technology, By Product, By Therapeutic Area, By End User, By Region and Competition

  • Report
  • March 2023
  • 112 Pages
  • Global
From
United Kingdom Renal Denervation Market, By Technology (Ultrasound Ablation, Radiofrequency Ablation, Pharmacologic Ablation, Micro-infusion), By Product, By Therapeutic Area, By End User, By Region, Competition Forecast & Opportunities, 2027 - Product Thumbnail Image

United Kingdom Renal Denervation Market, By Technology (Ultrasound Ablation, Radiofrequency Ablation, Pharmacologic Ablation, Micro-infusion), By Product, By Therapeutic Area, By End User, By Region, Competition Forecast & Opportunities, 2027

  • Report
  • July 2022
  • 78 Pages
  • United Kingdom
From
Alcoholic Liver Disease Patient Pool Analysis, Market Size and Market Forecast APAC - 2034 - Product Thumbnail Image

Alcoholic Liver Disease Patient Pool Analysis, Market Size and Market Forecast APAC - 2034

  • Report
  • February 2024
  • 120 Pages
  • Asia Pacific
From
Non-Alcoholic Fatty Liver Disease (NAFLD) Patient Pool Analysis, Market Size and Market Forecast APAC - 2034 - Product Thumbnail Image

Non-Alcoholic Fatty Liver Disease (NAFLD) Patient Pool Analysis, Market Size and Market Forecast APAC - 2034

  • Report
  • February 2024
  • 120 Pages
  • Asia Pacific
From
Nonalcoholic Steatohepatitis (NASH) Patient Pool Analysis, Market Size and Market Forecast APAC - 2034 - Product Thumbnail Image

Nonalcoholic Steatohepatitis (NASH) Patient Pool Analysis, Market Size and Market Forecast APAC - 2034

  • Report
  • February 2024
  • 120 Pages
  • Asia Pacific
From
Liver Fibrosis Patient Pool Analysis, Market Size and Market Forecast APAC - 2034 - Product Thumbnail Image

Liver Fibrosis Patient Pool Analysis, Market Size and Market Forecast APAC - 2034

  • Report
  • February 2024
  • 120 Pages
  • Asia Pacific
From
Liver Cirrhosis Patient Pool Analysis, Market Size and Market Forecast APAC - 2034 - Product Thumbnail Image

Liver Cirrhosis Patient Pool Analysis, Market Size and Market Forecast APAC - 2034

  • Report
  • February 2024
  • 120 Pages
  • Asia Pacific
From
Primary Sclerosing Cholangitis (PSC) Patient Pool Analysis, Market Size and Market Forecast APAC - 2034 - Product Thumbnail Image

Primary Sclerosing Cholangitis (PSC) Patient Pool Analysis, Market Size and Market Forecast APAC - 2034

  • Report
  • February 2024
  • 120 Pages
  • Asia Pacific
From
Focal segmental glomerulosclerosis (FSGS) Patient Pool Analysis, Market Size and Market Forecast APAC - 2034 - Product Thumbnail Image

Focal segmental glomerulosclerosis (FSGS) Patient Pool Analysis, Market Size and Market Forecast APAC - 2034

  • Report
  • February 2024
  • 120 Pages
  • Asia Pacific
From
Chronic Hepatitis B Patient Pool Analysis, Market Size and Market Forecast APAC - 2034 - Product Thumbnail Image

Chronic Hepatitis B Patient Pool Analysis, Market Size and Market Forecast APAC - 2034

  • Report
  • February 2024
  • 120 Pages
  • Asia Pacific
From
Diabetic Kidney Disease (DKD) - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Diabetic Kidney Disease (DKD) - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • January 2024
  • 189 Pages
  • Global
From
Lupus Nephritis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Lupus Nephritis - Epidemiology Forecast - 2032

  • Report
  • January 2024
  • 84 Pages
  • Global
From
IgA Nephropathy (IgAN) - Epidemiology Forecast - 2032 - Product Thumbnail Image

IgA Nephropathy (IgAN) - Epidemiology Forecast - 2032

  • Report
  • July 2023
  • 100 Pages
  • Global
From
Chronic Kidney Disease - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

Chronic Kidney Disease - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • April 2023
  • 246 Pages
  • Global
From
Primary Biliary Cholangitis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Primary Biliary Cholangitis - Epidemiology Forecast - 2032

  • Report
  • February 2023
  • 97 Pages
  • Global
From
Primary Biliary Cholangitis - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

Primary Biliary Cholangitis - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • February 2023
  • 195 Pages
  • Global
From
Liver Fibrosis - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

Liver Fibrosis - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • August 2022
  • 239 Pages
  • Global
From
Liver Fibrosis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Liver Fibrosis - Epidemiology Forecast - 2032

  • Report
  • August 2022
  • 119 Pages
  • Global
From
Loading Indicator

The Liver and Kidney Disorders Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs to treat diseases and disorders of the liver and kidneys. These drugs are used to treat a variety of conditions, including hepatitis, cirrhosis, kidney failure, and other kidney-related diseases. The market is highly competitive, with many companies vying for market share. The market is driven by the increasing prevalence of liver and kidney diseases, as well as the development of new treatments and technologies. Additionally, the rising demand for better treatments and the increasing availability of generic drugs are also contributing to the growth of the market. Some of the major companies in the Liver and Kidney Disorders Drugs market include Pfizer, Merck, Novartis, Sanofi, GlaxoSmithKline, AstraZeneca, Bristol-Myers Squibb, and AbbVie. These companies are engaged in the development and production of drugs to treat liver and kidney diseases. Show Less Read more